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Background: Novel cancer biomarkers like microRNA (miRNA) are promising tools to gain a better 
understanding of lung cancer pathology and yield important information to guide therapy. In recent 
years, new less invasive methods for the diagnosis and staging of NSCLC have become key tools in 
thoracic oncology and the worldwide spread of endobronchial ultrasound transbronchial needle aspiration 
(EBUS-TBNA). However, appropriate specimen handling is mandatory to achieve adequate results and 
reproducibility. The aim of this single centre prospective study was to evaluate the feasibility of a complete 
miRNA expression profile in fresh NSCLC cell lines obtained by EBUS-TBNA.
Methods: Patients with proven NSCLC underwent EBUS-TBNA for the diagnosis of suspect lymph 
node metastasis, and cytological specimens were collected for epithelial cell culture and miRNA expression 
analysis. To validate the miRNA expression profile, we compared the results from EBUS-TBNA NSCLC 
specimens with those obtained from formalin-fixed paraffin-embedded (FFPE) mediastinoscopy specimens. 
Results: Analysis of the miRNA expression profiles of three independent EBUS-TBNA-derived primary 
cell lines allowed the screening of 377 different human miRNAs. One hundred and fifty miRNAs were 
detected in all cell lines. Analysis of the miRNA expression profile in mediastinoscopy specimens showed a 
strong similarity in the clusters analysed. 
Conclusions: The miRNA expression profile is feasible and reliable in EBUS-TBNA specimens. 
Validation of this protocol in fresh cytological specimens represents an effective and reproducible method to 
correlate translational and clinical research.
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Introduction
Lung cancer is the leading cause of death in industrialized 
nations and is growing in young people and women (1). 
Despite large studies devised to develop new strategies for 
early diagnosis to increase chemotherapy response and 
prognosis, mortality remains high and effective therapies 
for advanced lung cancer are still lacking (2). A better 
understanding of lung cancer biology and the discovery of 
novel cancer biomarkers are paramount to achieve effective 
therapies especially for patients with advanced non-small 
cell lung cancer (NSCLC).
Recent studies showed that microRNA (miRNA) 
could be ideal candidate biomarkers for cancer prognosis 
since their dysregulation was found to correlate with the 
onset and progression of several malignancies including 
lung cancer (3,4). miRNA can be accurately analysed in 
(formalin-fixed paraffin-embedded) FFPE and in fresh 
tissue biopsies (5). In addition, miRNA is present in 
biological fluids (blood, plasma, saliva and urine) and are 
altered in asymptomatic early stage lung cancer patients (6). 
Different miRNA expression profiles were found to be 
associated with different lung cancer subtypes and there 
is evidence that miRNAs could play a role in targeted 
therapy in different oncological settings (7-9). Despite the 
potential clinical value of miRNA signatures, the clinical 
utility of identified signatures has yet to be demonstrated. 
Recent studies showed that endobronchial ultrasound 
transbronchial needle aspiration (EBUS-TBNA) provides 
adequate cytological specimens for lung cancer diagnosis 
and staging, including detection of the major genetic 
alterations identified in lung cancer: epidermal growth factor 
receptor-tyrosine kinase (EGFR) mutation status, anaplastic 
lymphoma kinase fusion genes (ALK), and Kirsten ras 
oncogene homologue (KRAS) mutation status (10).  
The present study describes a strategy for high-
throughput miRNA expression profile analysis of lung cancer 
lymph nodal metastasis using primary cell lines established 
from EBUS-TBNA samples. To validate the EBUS-
TBNA miRNA profile, the results were compared with 
those obtained from mediastinoscopies, the “gold standard” 
procedure for mediastinal staging in NSCLC patients. FFPE 
biopsies samples were obtained from mediastinoscopies 
surgical specimens present in our tissue bank. 
Methods
The institutional ethical committee approved this 
prospective single centre study (registration number: 
R65/14-IEO76), and informed consent was obtained. 
Patients with proven lung cancer underwent routine EBUS-
TBNA for the diagnosis of suspect lymph node metastasis, 
and cytological specimens were collected for epithelial cell 
culture and subsequent transcriptomic miRNA expression 
analysis.
EBUS-TBNA procedures
EBUS-TBNA was performed under local anaesthesia 
(1% lidocaine) and moderate sedation provided by 
an anaesthesiologist with spontaneous ventilation. 
All procedures were performed by the same team of 
interventional pulmonologists using a convex-probe (EBUS 
Convex Probe BF-UC180F; Olympus) and a dedicated 
ultrasound processor (EU-ME2; Olympus). EBUS-TBNA 
specimens were collected with a 22 gauge dedicated needle 
(Vizishot NA-201SX-4022; Olympus). 
A very small amount of the aspirated material was pushed 
out by the internal stylet and smeared onto glass slides 
for immediate on-site evaluation [rapid on site evaluation 
(ROSE)]. The remaining aspirate and other needle passages 
were put into saline solution for cell block processing and 
histological evaluation. One dedicated needle passage was 
put into a culture basal medium for primary cell cultures. 
Primary cell culture
The dedicated EBUS-TBNA specimen was processed 
within 30 minutes after the end of the procedure and placed 
in a sterile falcon filled with 5 mL of cell culture basal 
medium Ham’s F12/DMEM 1:1 supplemented with 1% 
foetal bovine serum, 50 ng/mL L-glutamine, 100 U/mL 
penicillin, 100 μg/mL streptomycin, 10 μg/mL gentamicin, 
0.5 μg/mL amphotericin B, 10 μg/mL human transferrin, 
1 μg/mL human insulin, 1μg/mL hydrocortisone, 10 mM 
Hepes pH 7.5, 50 μM/L-ascorbic acid, 15 nM sodium 
selenite, 0.1 mM ethanolamine, and 50 ng/mL cholera 
toxin. EBUS-TBNA samples were spun down for 5 min at 
1,000 g at RT, resuspended in 3 mL of complete medium 
further supplemented with 10 nM epidermal growth 
factor EGF, 35 μg/mL bovine pituitary extract, and 10 nM 
triiodothyronine, and cultured on six-well collagen I-coated 
plates (Collagen Cellware, Biocoat, Corning, USA) in a 
humidified incubator with 5% CO2. Primary cells were 
grown for 6 to 12 days and washed twice with PBS prior to 
total RNA extraction. 
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Immunofluorescence
Immunofluorescence was used to check the expression 
of lung epithelial (CCA, for bronchiolar epithelium, 
and SP-C, for alveolar epithelium) and neuroendocrine 
(chromogranin A) markers on EBUS-derived and plated 
cells. All the following steps were carried out at room 
temperature. Permeabilization was achieved with 0.2% 
BSA, 0.1% Triton, and 1× PBS for 10 min, followed by one 
wash with 1x PBS. Blocking was carried out with 2% BSA 
for 30 min. Primary antibodies were added and left for 1 h. 
Following two washes with 1x PBS, secondary antibodies 
were added for 30 min (light protected), then another 
two washes with 1× PBS were performed. Post-fixing 
was achieved with 2% PFA for 1 min, followed by DAPI 
staining for 5 min and another two washes with 1x PBS. A 
final post-fixing was done with 2% PFA followed by one 
final wash with 1× PBS. Slides were mounted and analysed. 
The following antibodies were used: CCA, goat polyclonal 
raised against a peptide mapping near the mouse protein 
C-terminal (CC10 T-18, Santa Cruz Biotechnologies, sc-
9772), dilution 1:400; secondary antibody, donkey anti 
goat Cy3, dilution 1:400; SP-C, rabbit polyclonal raised 
against a.a. 1–20 from human protein N-terminal (Anti-
Prosurfactant Protein C, pro-SP-C, Millipore, AB3786), 
dilution 1:1,000; secondary antibody, donkey anti rabbit 
Alexa 647, dilution 1:100; chromogranin A, rabbit 
polyclonal raised against the human protein C-terminal 
(Abcam, Ab15160), dilution 1:100; secondary antibody, 
donkey anti rabbit Alexa 647, dilution 1:100.
RNA/miRNA extraction and quantitative real-time PCR 
analysis
Total RNA was extracted from EBUS-TBNA primary cells 
using the AllPrep DNA/RNA/miRNA Universal Kit and 
from FFPE tissue samples obtained by mediastinoscopy 
using the AllPrep DNA/RNA FFPE Kit, both protocols 
automated on QIAcube, according to the manufacturer's 
instructions (Qiagen, Hilden, Germany).
Following histological assessment of each FFPE tissue 
block, RNA was extracted from microdissected areas of one 
to two tissue sections (5–10 μm thick) on glass slides with 
adequate tumour cellularity (>60%), selected by a pathologist. 
The total quantity of RNA extracted in each sample 
(EBUS-TBNA and mediastinoscopies) is shown in Table 1. 
Total RNA extracted from EBUS-TBNA-derived 
primary cells was measured using the NanoDrop® ND-
1,000 spectrophotometer and reverse transcribed with the 
SuperScript VILO cDNA Synthesis Kit (Thermo Fisher 
Scientific) in 20 μL of final volume and 5 ng of cDNA/
reaction were analysed by PCR. Quantitative PCR was 
performed using UPL probes (Universal ProbeLibrary; 
Roche, Switzerland) and primers specific for KRT5 
and KRT14 (expressed in epithelial basal cells), KRT18 
(expressed in bronchial and alveolar epithelium), or PTPRC 
and PECAM-1 (expressed in endothelial cells), or PDGFRB 
(expressed in mesenchymal cells) and LCP2 (expressed in 
lymphocyte), in a final volume of 15 μL of LightCycler 
480 Probe Master mix (Roche). UPL probe and primer 
combinations specific for each target were designed with the 
Table 1 Cohort of EBUS-TBNA primary cells and mediastinoscopies samples with total RNA extracted
Type of sample Sex Age Histology RNA total ng
EBUS #1 M 72 Squamous cell carcinoma 1,698
EBUS #2 M 64 NSCLC 629
EBUS #3 M 62 Squamous cell carcinoma 4,007
EBUS #4 M 69 Squamous cell carcinoma 3,006
EBUS #5 M 73 Adenocarcinoma 467
MED #1 F 70 Adenocarcinoma 578
MED #2 M 59 Adenocarcinoma 260
MED #3 M 52 Adenocarcinoma 422
MED #4 M 60 Adenocarcinoma 206
MED #5 M 59 Squamous cell carcinoma 203
M, male; F, female; EBUS-TBNA, endobronchial ultrasound transbronchial needle aspiration; EBUS, EBUS-TBNA primary cells; MED,  
mediastinoscopies FFPE samples.
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free web-based ProbeFinder Software (Roche) and reported 
in Table S1. Real-time quantitative PCR analysis (RT-qPCR) 
reaction was run in a LightCycler 480 real-time PCR 
instrument (Roche) in 96 wells format, using the following 
thermal cycling conditions: 95 ℃ for 10 min, followed by 45 
cycles of 95 ℃ for 10 s and 72 ℃ for 60 s and final cooling 
at 40 ℃ for 30 s.
For each mRNA target in each sample, the expression 
level was measured in triplicate and the average Cq was 
calculated. Data (average Cq) were normalized to the 
average Cq value of the two endogenous reference genes 
(GAPDH and GUSB) using the 2−ΔCq method.
For miRNA expression analysis, 10 ng of total RNA, 
measured using the Quant-iT™ RiboGreen® RNA assay 
kit (Thermo Fisher Scientific), were reverse transcribed 
with Megaplex™ miRNA-specific stem-loop RT Primers 
Human Pool A v 2.1 (Thermo Fisher Scientific) and 
TaqMan® MicroRNA reverse transcription kit (Thermo 
Fisher Scientific) according to the manufacturer’s 
instructions; 5 μL of reverse transcribed product were 
pre-amplified for 14 cycles using the TaqMan PreAMP 
Mastemix and Megaplex PreAMP primers Pool A v 2.1 
according to the manufacturer’s instructions (Thermo 
Fisher Scientific). The PCR reaction was performed using 
the TaqMan Universal Master Mix II, No AmpErase UNG 
(Thermo Fisher Scientific) by loading 100 μL of the pre-
amplified mixture (final dilution 1:200) in each of the eight 
lanes of the TaqMan® Low Density Array miRNA Panel A v 
2.0 (Thermo Fisher Scientific). Real-Time PCR was carried 
out on the ViiA7 Real-Time PCR System (Thermo Fisher 
Scientific) using the manufacturer’s recommended cycling 
conditions (50 ℃ for 2 min, 95 ℃ for 10 min, followed by 40 
cycles at 95 ℃ for 15 s and 60 ℃ for 1 min) and setting an 
automatic threshold. Cq data of miRNAs were normalized 
using the RNU6-1 as housekeeping gene. Normalized 
Cq (Cqn) were calculated as previously described (9). 
Hierarchical clustering analysis was performed using Cluster 
3.0 for Mac OS X (http://bonsai.hgc.jp/~mdehoon/software/
cluster/software.htm) and Java Treeview (http://jtreeview.
sourceforge.net). Spearman rank correlation and centroid 
clustering methods were used on Cqn data. 
Results
The immunofluorescence analysis using known markers of 
alveolar and neuroendocrine cells constituting the airway 
epithelium confirmed the lung origin of the established 
EBUS primary cell lines (Figure 1A). 
RT-qPCR revealed a high expression of epithelial 
markers in EBUS-derived primary cell lines which was 
almost absent in the EBUS-TBNA specimen (Figure 1B), 
while the EBUS-TBNA samples were positive to the 
expression of non-epithelial markers (Figure 1B). 
As a control, the expression of non-epithelial markers was 
checked in two commercial cell lines of non-epithelial origin 
(HL60 and HUVEC) and proved positive (Figure 1C). 
These data confirmed the successful establishment of lung 
epithelial cells from EBUS-TBNA specimens.
We performed 15 EBUS-TBNA procedures in patients 
with suspect lymph node NSCLC metastasis for primary 
cell cultures. Seven out of 15 samples presented an adequate 
growth on culture and in five patients was possible to 
extract RNA followed by miRNA profiling analysis. The 
percentage of adequate growth on culture was about 30% 
of the total EBUS-TBNA sampled. A flow-chart of the 
procedure is shown in Figure 2.
Analysis of the miRNA expression profile of the five 
independent EBUS-TBNA-derived primary cell lines using 
TaqMan® Array Human MicroRNA Card A allowed the 
screening of 377 different human miRNAs; 130 miRNAs 
(~35% of the total analyzable) were detected (with Cqn 
≤30) in all five cell lines. Relative quantities of miRNAs 
detected in all five EBUS-primary cell lines ranged from 
22 to 26 Cqn (i.e., the 25th and 75th quartile intervals) 
(Figure 3A; Table S2). 
Analysis of the miRNA expression profile of microdissected 
formalin-fixed lung cancer tissue (“MED” samples; N=5) 
compared with the profile of EBUS-primary cells (Figure 3A) 
showed a slight decrease in the average number of miRNA 
detected (i.e., with Cqn ≤30) in all five FFPE samples (109 vs. 
130; Figure 3A). This was probably due to a partial degradation 
of some miRNA species in FFPE samples. 
A total of 102 miRNAs (~78% in EBUS-TBNA primary 
cell lines and ~94% of FFPE mediastinoscopies) were 
commonly detected in all samples analysed (with Cqn 
≤30), confirming a strong similarity of the two miRNA 
profiles as also shown in hierarchical cluster analysis 
(Figure 3B). A list of miRNAs detected in EBUS-primary 
cells, mediastinoscopy samples and common miRNAs are 
shown in Table S2.
Discussion
New trends in thoracic oncology are characterized by 
non-invasive therapies and less-invasive methods for the 
diagnosis and staging of advanced NSCLC, and targeted 
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Figure 1 Biological characterization of EBUS derived primary cell lines. (A) Immunofluorescence analysis of primary cell lines obtained 
from two EBUS-TBNA samples. Left: expression of the Clara cell–specific marker (CCA) and surfactant protein C (SP-C) indicates 
bronchoalveolar cells in the EBUS specimen of a lung adenocarcinoma. Right: expression of chromogranin indicates neuroendocrine 
cells in the EBUS specimen of a lung adenocarcinoma with neuroendocrine features. Below, visible microscope analysis representing the 
morphology of the two cell lines obtained; the neuroendocrine cells appeared with the characteristic spindle-shaped morphology; (B) RT-
qPCR analysis of a panel of genes expressed preferentially in non-epithelial cells (i.e., non-epithelial marker) or epithelial cells (i.e., epithelial 
markers). In blue, gene expression level in all EBUS-TBNA samples. In red, gene expression level in the established primary cell lines; 
(C) RT-qPCR analysis of two commercial cell lines of non-epithelial origin used as control: HL60 (promyeloblast cell type) and HUVEC 
(endothelial cell type). Normalized expression refers to the expression of genes normalized to the average of the expression of GUSB and 
GAPDH (i.e., the -dCT), used as housekeeping genes. EBUS, EBUS-TBNA primary cells; RT-qPCR, real-time quantitative PCR analysis.
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Figure 2 Flow chart of EBUS-TBNA primary cell culture procedure. miRNA, microRNA; EBUS-TBNA, endobronchial ultrasound 
transbronchial needle aspiration.
Figure 3 MicroRNA expression profile analysis of EBUS and MED samples. (A) Pie charts of the number of detected (Cqn ≤30; in orange), 
or undetected (Cqn >30; in blue) microRNA in all the primary cells obtained from EBUS (N=5) or in all mediastinoscopy FFPE samples, 
i.e., “MED” samples (N=5); (B) hierarchical cluster analysis of the expression profile of the 102 commonly detected miRNAs in EBUS (N=5) 
and MED samples (N=5). Heatmap indicates the expression level of each individual miRNA analyzed. Normalized Cq values were colour-
coded and described by the scale bar. Cqn, normalized Cq; EBUS, EBUS-TBNA primary cells; miRNA, microRNA; FFPE, formalin-fixed 
paraffin-embedded; MED, mediastinoscopy FFPE samples.
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therapies (11) designed to reduce patient discomfort and 
complications and improve survival rates.
Surgical histological specimens have been supplanted 
by  EBUS-TBNA in  d i f ferent  c l in ica l  scenar ios , 
especially in lung cancer diagnosis and staging (12). In 
recent years, several studies have demonstrated that 
EBUS-TBNA reaches the same percentage of diagnosis 
as surgical biopsies, and allows molecular analyses and 
mutation detections for target therapies in advanced 
lung cancer patients (10). Due to its low invasiveness, 
EBUS-TBNA can also be repeated on “long survival” 
patients to re-characterize molecular status for personalized 
treatment.
Different studies have investigated the association 
between miRNA alterations and lung cancer onset and 
progression. miRNAs were shown to be prognostic 
factors, or early diagnostic markers, or more intriguingly, 
factors determining chemotherapy or biological drug 
responses (5). 
Developing novel biomarkers in conjunction with less 
invasive methods of diagnosis and staging of NSCLC 
patients, especially EBUS-TBNA, is paramount to offer 
patients optimal care with the new perspectives of targeted 
therapies. The integration of miRNA screening studies with 
clinical protocols is mandatory to transfer the proposed 
miRNA biomarkers to the clinical setting. Standardizing 
methods for collection of biological samples and optimizing 
miRNA profile analyses, particularly when starting from 
limited amounts of specimens, represents a definitive 
strategy to increase the assessment of proposed biomarkers 
in clinical studies.
As previously reported, miRNAs are resistant to 
degradation and can be easily identified in FFPE specimens, 
but few data are available on the feasibility of miRNA 
expression analyses in cytological specimens. A recent study 
investigated mRNA and miRNA expression profiles in 
EBUS-TBNA stored specimens (13). However, it did not 
address the purity of the samples to derive miRNA/mRNA 
expression profiles in terms of lung cancer cells fraction, a 
major issue since miRNAs have been shown to be tissue-
specific (14).
The  u se  o f  p r imary  ce l l  l i ne s  in s t ead  o f  the 
completely f ixed cytological  specimens col lected 
from EBUS-TBNA has been never described, but 
should guarantee a higher specificity of the miRNA 
expression profile, avoiding “contamination” of the 
neoplastic cell miRNA profile by other non-epithelial 
cells (lymphocytes, blood and stromal cells) which are 
abundant in lymph node samples. 
This study obtained primary cell cultures from EBUS-
TBNA specimens removing most of the non-epithelial 
cells (lymphocytes, blood and stromal cells) that might 
affect the gene expression profile of NSCLC cellularity 
and miRNA results. The results demonstrate the feasibility 
of obtaining pure populations of primary NSCLC cells 
from EBUS-TBNA specimens and a complete miRNA 
expression profile analysis, which strongly correlates 
with those obtained from microdissected lymph nodal 
metastases from mediastinoscopy specimens. In addition, 
the establishment of EBUS-TBNA primary NSCLC cell 
lines also provides experimental models to test the role of 
these miRNAs in the biology of lung cancer metastases, 
which may also have therapeutic indications. Our results 
are promising for the management of advanced NSCLC 
patients. The possibility to use EBUS-TBNA specimens 
for a primary cell culture and whole miRNA expression 
profiles provides an excellent tool in the personalized 
therapy of advanced lung cancer patients. On the basis 
of the present results, we have designed a prospective 
study to collect EBUS-TBNA primary NSCLC cell lines 
to evaluate the expression of a miRNA signature profile 
in stage IIIA NSCLC patients. We plan to evaluate a 
miRNA signature based on response to chemotherapy 
that could predict a good prognosis and single out 
the best candidates for therapy, a crucial point in 
personalized treatment era. 
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Supplementary
Table S1 List of primers and probes (UPL, Roche) used for RT-qPCR analyses of the panel of epithelial and non-epithelial genes
Gene symbol RefSeq UPL probe number Amplicon size Primer forward Primer reverse
KRT5 NM_000424.3 63 67 CAGCGTCAAATTTGTCTCCAC TGCAGCAGGTTCTTAGCTCTT
KRT14 NM_000526.4 19 79 CCTCCTCCCAGTTCTCCTCT ATGACCTTGGTGCGGATTT
KRT18 NM_000224.2 70 77 AAGCTGGAGGCTGAGATCG TCCAAGGCATCACCAAGATTA
PTPRC NM_002838.4 41 73 GAAAAGCTCCCTGAAGCAAA AATGTTCTGGCCCCTCAGT
PECAM-1 NM_000442.4 75 77 TTGGAAATACACAGTGCTGACC TGGTTTTCCCATTTGTGGAG
PDGFRB NM_002609.3 61 72 CGGGACCTCTTTCACTACCC CTCATTTGCCCTCTTTGTCC
LCP2 NM_005565.3 34 63 TTATAGCCGAGCAAATGAACC CCAAGGCTGATTGATCTCGT
GAPDH NM_002046.5 45 72 CAAGGAGTAAGACCCCTGGAC CCCAGCAGTGAGGGTCTCT
GUSB NM_000181.3 84 61 CCTTCCTCCCCGAGTCAG GAACAGTCCAGGAGGCACTT
UPL, universal probelibrary (roche); RefSeq, NCBI reference sequence database; RT-qPCR, real-time quantitative PCR analysis.
Table S2 The expression data of the 377 miRNA analysed. Target name, the official Assay ID of the TaqMan® Low Density Array microRNA Panel A v 2.0 (Thermo Fisher Scien-
tific) is shown 
Target name EBUS #1 EBUS #2 EBUS #3 EBUS #4 EBUS #5 MED #1 MED #2 MED #3 MED #4 MED #5 DETECTED
hsa-let-7a-4373169 21.15 20.48 20.88 20.84 20.53 21.02 22.92 21.80 21.12 21.37 Commonly detected in all
hsa-let-7c-4373167 26.11 25.19 26.20 23.51 24.96 23.45 26.30 23.64 23.02 22.87 Commonly detected in all
hsa-let-7d-4395394 23.74 23.17 23.33 22.97 22.67 23.06 25.32 23.78 22.46 23.24 Commonly detected in all
hsa-let-7e-4395517 20.63 20.44 20.08 20.49 19.91 19.25 21.19 20.14 19.56 20.10 Commonly detected in all
hsa-let-7f-4373164 23.75 23.29 23.84 23.11 22.77 24.63 26.25 24.01 24.46 24.11 Commonly detected in all
hsa-let-7g-4395393 24.02 23.68 24.08 23.74 22.74 23.42 25.21 24.37 23.26 22.60 Commonly detected in all
hsa-miR-9-4373285 27.16 28.05 25.28 21.98 20.13 28.12 27.98 27.06 19.06 25.07 Commonly detected in all
hsa-miR-10a-4373153 27.04 27.03 24.94 25.54 23.81 25.04 26.23 23.33 21.08 25.22 Commonly detected in all
hsa-miR-15a-4373123 26.31 26.93 27.89 28.75 24.38 28.00 27.32 25.65 21.43 24.93 Commonly detected in all
hsa-miR-15b-4373122 22.67 22.60 22.41 20.69 22.66 24.36 25.04 23.87 19.13 22.81 Commonly detected in all
hsa-miR-16-4373121 22.04 21.99 22.29 20.38 19.64 21.51 22.37 20.62 19.27 21.69 Commonly detected in all
hsa-miR-17-4395419 18.41 18.12 18.98 18.45 17.81 21.12 22.74 20.67 17.49 21.06 Commonly detected in all
hsa-miR-19a-4373099 22.60 21.89 23.36 22.41 21.05 25.92 27.33 24.04 14.52 25.32 Commonly detected in all
hsa-miR-19b-4373098 17.81 17.28 18.90 18.13 16.25 20.52 22.21 19.36 14.86 19.99 Commonly detected in all
hsa-miR-20a-4373286 18.35 17.96 19.10 18.24 17.06 21.74 23.22 21.11 19.24 21.25 Commonly detected in all
hsa-miR-20b-4373263 23.57 23.06 24.28 23.02 22.72 26.78 28.21 25.82 22.20 25.59 Commonly detected in all
hsa-miR-21-4373090 18.54 16.82 19.47 17.77 15.82 19.09 20.13 17.50 14.28 18.26 Commonly detected in all
hsa-miR-22-4373079 25.35 22.41 25.73 24.91 21.38 26.00 28.12 23.72 20.50 23.96 Commonly detected in all
hsa-miR-24-4373072 16.28 15.20 17.58 16.79 16.66 18.71 20.82 19.12 15.45 18.53 Commonly detected in all
hsa-miR-25-4373071 24.08 23.52 23.91 22.04 23.96 25.13 26.30 22.39 21.16 23.13 Commonly detected in all
hsa-miR-26a-4395166 22.03 20.99 22.25 21.57 20.97 20.36 23.34 21.14 20.94 21.80 Commonly detected in all
hsa-miR-26b-4395167 23.64 22.82 24.60 24.07 22.04 23.43 26.16 23.35 24.08 23.64 Commonly detected in all
hsa-miR-27a-4373287 21.64 20.25 22.72 22.73 22.24 23.55 25.29 23.10 19.92 21.83 Commonly detected in all
hsa-miR-27b-4373068 23.16 22.68 24.25 23.06 25.17 24.13 26.91 24.23 20.76 23.23 Commonly detected in all
hsa-miR-28-3p-4395557 24.54 23.37 24.02 23.59 22.08 23.20 25.12 22.04 19.94 22.24 Commonly detected in all
hsa-miR-28-5p-4373067 24.14 23.06 24.22 23.37 22.34 25.64 26.88 24.26 20.61 23.05 Commonly detected in all
hsa-miR-29a-4395223 20.63 18.71 21.41 21.61 19.63 20.97 22.75 20.93 17.78 19.64 Commonly detected in all
hsa-miR-29b-4373288 23.92 21.61 25.14 24.73 22.06 24.92 27.25 24.52 23.30 23.45 Commonly detected in all
hsa-miR-30b-4373290 19.63 19.11 20.98 18.92 19.79 16.87 21.00 20.41 18.20 19.02 Commonly detected in all
hsa-miR-30c-4373060 18.91 18.32 20.34 18.17 19.33 18.37 21.69 20.42 18.31 18.79 Commonly detected in all
hsa-miR-31-4395390 17.00 16.20 19.24 18.74 17.99 28.10 29.12 23.93 19.93 24.14 Commonly detected in all
hsa-miR-34a-4395168 22.21 21.23 20.41 22.78 20.22 22.94 24.28 22.59 19.07 21.27 Commonly detected in all
hsa-miR-92a-4395169 20.03 19.79 20.11 20.06 18.92 22.55 24.16 21.96 18.64 20.17 Commonly detected in all
hsa-miR-93-4373302 22.89 22.58 23.10 21.60 23.48 25.11 25.96 22.63 19.29 24.31 Commonly detected in all
hsa-miR-99a-4373008 19.41 19.64 18.94 20.65 19.48 23.50 25.32 21.71 22.07 21.37 Commonly detected in all
hsa-miR-99b-4373007 20.08 18.99 20.38 19.87 19.98 21.99 24.14 20.97 19.23 21.27 Commonly detected in all
hsa-miR-100-4373160 19.83 19.81 19.56 20.67 19.55 23.12 24.93 21.16 19.62 21.53 Commonly detected in all
hsa-miR-103-4373158 23.01 22.23 24.34 22.75 22.14 24.59 25.94 24.14 21.20 23.17 Commonly detected in all
hsa-miR-106a-4395280 18.56 18.15 19.26 18.52 17.73 21.13 22.79 20.71 17.52 21.14 Commonly detected in all
hsa-miR-106b-4373155 22.26 21.53 23.06 20.99 21.79 23.82 24.86 21.78 19.04 21.64 Commonly detected in all
hsa-miR-125a-5p-4395309 23.27 22.29 23.13 23.11 22.12 24.86 25.83 23.67 22.20 24.74 Commonly detected in all
hsa-miR-125b-4373148 21.30 21.25 19.92 20.92 20.89 21.80 23.20 20.94 20.12 21.31 Commonly detected in all
hsa-miR-126-4395339 25.02 23.10 26.28 23.81 22.13 19.10 20.44 19.94 17.30 18.86 Commonly detected in all
hsa-miR-127-3p-4373147 26.90 29.08 22.60 25.56 27.96 26.45 28.00 25.89 22.17 25.49 Commonly detected in all
hsa-miR-130a-4373145 24.05 22.42 24.62 23.69 22.94 23.75 26.31 25.25 22.22 24.91 Commonly detected in all
hsa-miR-130b-4373144 24.90 24.35 25.19 24.42 24.56 27.14 27.95 26.64 21.76 25.89 Commonly detected in all
hsa-miR-132-4373143 24.00 22.56 23.18 22.67 20.98 24.01 25.08 22.41 20.44 22.28 Commonly detected in all
hsa-miR-135b-4395372 22.65 21.31 26.22 22.82 21.04 23.07 25.90 25.07 22.96 27.79 Commonly detected in all
hsa-miR-139-5p-4395400 27.66 26.02 27.90 25.96 23.39 26.07 28.25 27.06 24.39 24.62 Commonly detected in all
hsa-miR-140-5p-4373374 25.85 24.33 25.78 26.21 26.01 24.35 25.49 23.46 19.35 23.92 Commonly detected in all
hsa-miR-141-4373137 22.28 20.84 25.33 21.94 19.84 22.67 25.02 22.04 20.14 21.72 Commonly detected in all
hsa-miR-145-4395389 27.76 25.83 21.21 22.09 23.60 20.31 21.79 21.20 15.08 19.43 Commonly detected in all
hsa-miR-146a-4373132 22.55 21.90 20.55 22.84 22.13 21.83 22.12 20.01 17.45 18.84 Commonly detected in all
hsa-miR-146b-5p-4373178 26.69 25.51 23.53 23.79 23.90 21.02 22.28 20.79 16.30 19.88 Commonly detected in all
hsa-miR-148a-4373130 25.29 24.15 25.40 24.10 25.02 24.45 26.92 24.01 22.56 24.62 Commonly detected in all
hsa-miR-149-4395366 22.54 21.49 22.95 21.93 23.76 27.12 28.14 26.68 23.06 24.38 Commonly detected in all
hsa-miR-150-4373127 25.99 27.89 27.69 27.27 26.46 20.34 19.89 18.86 19.17 15.70 Commonly detected in all
hsa-miR-152-4395170 25.43 23.59 24.61 23.30 24.07 23.90 26.13 24.09 21.76 23.56 Commonly detected in all
hsa-miR-181a-4373117 23.10 21.36 23.45 23.25 21.17 22.01 25.26 23.30 21.27 22.05 Commonly detected in all
hsa-miR-185-4395382 27.86 26.33 28.25 27.06 26.61 27.89 28.80 26.67 24.14 25.10 Commonly detected in all
hsa-miR-186-4395396 24.00 22.41 24.78 24.01 23.47 22.10 25.95 22.95 20.56 22.75 Commonly detected in all
hsa-miR-191-4395410 19.86 18.83 20.67 20.09 19.65 19.29 22.04 19.16 18.73 19.74 Commonly detected in all
hsa-miR-193a-5p-4395392 28.76 26.48 25.07 25.45 24.01 26.90 27.94 26.81 22.11 25.31 Commonly detected in all
hsa-miR-193b-4395478 19.86 17.98 20.19 19.13 18.84 22.36 23.17 20.04 16.65 21.66 Commonly detected in all
hsa-miR-194-4373106 27.72 26.09 29.03 25.21 23.22 28.87 28.57 27.51 24.55 27.01 Commonly detected in all
hsa-miR-197-4373102 22.89 21.41 22.72 22.39 23.18 23.63 25.10 22.64 20.94 20.71 Commonly detected in all
hsa-miR-199a-3p-4395415 29.19 29.02 22.43 24.17 26.97 22.59 24.10 22.20 19.00 22.04 Commonly detected in all
hsa-miR-200a-4378069 21.93 20.60 24.64 21.95 20.90 22.38 25.45 23.01 18.96 22.73 Commonly detected in all
hsa-miR-200b-4395362 20.96 19.88 23.25 20.85 19.94 22.34 25.29 21.90 20.07 23.50 Commonly detected in all
hsa-miR-200c-4395411 18.25 17.40 20.56 17.35 16.73 19.30 21.86 18.09 17.32 20.46 Commonly detected in all
hsa-miR-203-4373095 20.16 18.18 22.91 19.44 17.73 22.65 26.48 23.39 22.82 20.12 Commonly detected in all
hsa-miR-210-4373089 21.17 20.39 22.60 20.81 21.74 20.94 23.19 20.57 19.55 20.11 Commonly detected in all
hsa-miR-218-4373081 23.82 23.10 23.79 22.23 26.67 22.92 24.99 24.97 20.18 21.58 Commonly detected in all
hsa-miR-221-4373077 20.00 19.07 19.49 20.58 22.31 24.72 26.24 24.16 20.28 23.00 Commonly detected in all
hsa-miR-222-4395387 18.13 17.06 18.75 18.10 18.09 19.28 21.26 18.42 16.48 18.73 Commonly detected in all
hsa-miR-223-4395406 22.66 24.26 25.24 23.65 23.36 20.92 21.35 16.93 16.12 19.26 Commonly detected in all
hsa-miR-224-4395210 24.01 23.25 24.74 21.53 22.21 27.20 28.07 24.44 21.15 22.95 Commonly detected in all
hsa-miR-301a-4373064 24.04 23.22 26.26 22.87 23.79 24.84 27.59 26.10 22.47 26.05 Commonly detected in all
hsa-miR-320-4395388 21.66 21.13 22.14 20.60 20.04 21.74 22.56 20.32 20.07 21.00 Commonly detected in all
hsa-miR-324-3p-4395272 27.10 26.22 27.69 25.95 26.10 26.93 29.61 26.30 22.61 25.19 Commonly detected in all
hsa-miR-324-5p-4373052 24.37 23.75 24.98 22.17 24.05 26.14 27.93 25.57 21.26 23.93 Commonly detected in all
hsa-miR-331-3p-4373046 20.66 19.23 21.93 19.90 19.14 20.79 23.29 21.11 18.89 21.06 Commonly detected in all
hsa-miR-339-5p-4395368 24.47 23.55 25.19 24.26 22.51 25.64 27.37 24.87 22.73 23.62 Commonly detected in all
has-miR-155-4395459 24.85 25.17 24.53 26.27 27.70 24.72 24.83 22.08 16.56 20.23 Commonly detected in all
hsa-let-7b-4395446 20.87 20.41 20.46 20.30 20.09 18.86 20.25 18.96 17.52 19.25 Commonly detected in all
hsa-miR-342-3p-4395371 23.87 23.63 25.23 24.08 24.07 21.13 22.79 20.95 16.96 19.01 Commonly detected in all
hsa-miR-345-4395297 24.95 24.97 26.48 25.37 26.14 29.03 29.71 27.59 20.72 24.33 Commonly detected in all
hsa-miR-365-4373194 23.86 21.89 23.33 22.70 22.38 28.89 29.95 27.96 18.87 24.27 Commonly detected in all
hsa-miR-374a-4373028 23.26 21.93 24.42 23.30 22.61 22.91 25.18 22.36 23.64 22.74 Commonly detected in all
hsa-miR-374b-4381045 23.08 21.88 23.47 22.51 22.61 23.25 25.50 23.07 23.24 22.99 Commonly detected in all
hsa-miR-423-5p-4395451 27.32 26.42 27.15 26.18 26.14 27.93 29.05 26.19 23.76 27.01 Commonly detected in all
hsa-miR-484-4381032 21.87 21.56 21.93 21.44 20.12 21.58 22.68 20.59 17.92 20.87 Commonly detected in all
hsa-miR-532-3p-4395466 25.48 23.60 25.26 24.11 24.75 23.12 27.21 24.72 22.47 24.00 Commonly detected in all
hsa-miR-532-5p-4380928 25.22 23.26 25.03 23.97 24.53 23.99 27.50 25.03 20.68 25.30 Commonly detected in all
hsa-miR-574-3p-4395460 22.78 21.64 22.24 22.00 22.01 21.98 23.91 21.43 20.04 22.61 Commonly detected in all
hsa-miR-642-4380995 26.79 25.86 28.51 27.02 24.51 27.88 29.23 27.33 23.83 26.02 Commonly detected in all
hsa-miR-660-4380925 25.33 23.51 25.93 24.74 23.88 23.33 26.70 24.66 21.97 23.95 Commonly detected in all
hsa-miR-744-4395435 24.56 23.39 24.93 23.91 24.25 25.63 27.93 25.38 22.56 24.98 Commonly detected in all
hsa-miR-886-3p-4395305 23.66 23.57 22.45 24.83 22.11 25.33 24.83 26.10 23.00 21.34 Commonly detected in all
hsa-miR-886-5p-4395304 23.53 24.03 24.93 25.36 23.05 25.08 24.44 26.71 20.29 20.76 Commonly detected in all
hsa-miR-212-4373087 26.78 25.90 26.77 26.15 25.50 27.98 28.59 26.08 24.19 23.97 Commonly detected in all
hsa-miR-376c-4395233 27.68 28.87 24.29 26.90 26.89 28.20 29.64 28.23 23.46 26.77 Commonly detected in all
hsa-miR-503-4373228 29.28 26.21 29.11 29.35 28.01 ND ND ND ND ND EBUS detected
hsa-miR-18b-4395328 24.66 23.62 24.90 24.01 23.66 ND ND ND ND 25.82 EBUS detected
hsa-miR-18a-4395533 24.06 23.35 24.89 23.70 23.54 ND ND 29.14 22.80 25.62 EBUS detected
hsa-miR-23a-4373074 24.59 23.39 25.08 24.64 24.71 ND 27.06 24.78 ND 25.03 EBUS detected
hsa-miR-98-4373009 24.22 23.26 25.77 22.73 23.68 ND 27.12 27.60 24.41 ND EBUS detected
hsa-miR-101-4395364 28.35 28.06 29.72 28.77 26.70 27.60 ND 29.06 ND 27.30 EBUS detected
hsa-miR-107-4373154 28.71 27.99 28.80 28.10 28.25 29.54 ND 29.12 ND ND EBUS detected
hsa-miR-128-4395327 27.02 26.15 27.11 26.58 27.27 29.28 ND 26.93 23.51 26.99 EBUS detected
hsa-miR-148b-4373129 27.20 26.02 28.40 25.86 25.94 29.19 ND 27.12 ND ND EBUS detected
hsa-miR-183-4395380 26.53 25.14 28.27 24.73 25.68 29.72 ND 29.84 ND ND EBUS detected
hsa-miR-205-4373093 18.74 17.62 20.53 18.55 27.39 28.99 ND 22.88 ND 18.34 EBUS detected
hsa-miR-330-3p-4373047 26.35 25.47 27.86 24.91 26.98 ND ND 28.36 ND 27.04 EBUS detected
hsa-miR-339-3p-4395295 27.01 26.35 27.09 26.26 24.91 28.88 ND 29.58 22.39 25.11 EBUS detected
hsa-miR-340-4395369 28.64 27.20 29.22 28.07 27.98 29.49 ND 28.56 ND ND EBUS detected
hsa-miR-362-5p-4378092 28.09 26.06 28.16 26.99 27.06 27.01 ND 28.14 ND ND EBUS detected
hsa-miR-376a-4373026 27.95 29.40 24.24 26.47 27.01 29.02 ND 29.82 ND ND EBUS detected
hsa-miR-411-4381013 28.93 29.71 25.43 28.02 28.84 29.20 ND 29.34 ND 27.23 EBUS detected
hsa-miR-424-4373201 28.24 24.86 28.22 28.15 26.07 29.44 ND 29.03 ND ND EBUS detected
hsa-miR-429-4373203 24.27 23.30 28.01 25.04 25.26 26.78 ND 28.16 ND ND EBUS detected
hsa-miR-452-4395440 28.20 27.33 28.68 26.10 27.48 29.64 ND 27.99 24.25 27.20 EBUS detected
hsa-miR-455-3p-4395355 24.69 24.40 24.50 25.48 27.03 28.60 29.18 ND 24.67 ND EBUS detected
hsa-miR-491-5p-4381053 28.47 26.97 28.15 28.06 27.83 27.29 ND 27.60 ND ND EBUS detected
hsa-miR-500-4395539 28.30 26.31 28.59 26.80 27.09 27.54 ND 28.50 ND ND EBUS detected
hsa-miR-505-4395200 27.72 27.05 27.92 27.93 28.23 29.46 ND 29.02 ND 26.96 EBUS detected
hsa-miR-597-4380960 28.05 26.83 29.05 27.41 27.47 ND ND 29.12 ND ND EBUS detected
hsa-miR-652-4395463 26.95 26.32 28.01 26.19 25.90 26.58 ND 29.03 22.93 27.77 EBUS detected
hsa-miR-671-3p-4395433 27.92 27.29 27.06 27.51 28.37 ND ND 29.64 24.69 27.51 EBUS detected
hsa-miR-708-4395452 23.69 22.20 23.83 22.57 27.58 ND ND 29.80 21.74 24.18 EBUS detected
hsa-miR-23b-4373073 26.58 25.68 27.22 25.42 29.45 26.78 29.85 28.34 ND ND EBUS detected
hsa-miR-29c-4395171 23.53 21.72 24.69 24.52 22.76 23.22 26.83 24.06 ND 21.70 EBUS detected
hsa-miR-95-4373011 29.72 28.06 28.76 26.62 27.64 27.22 29.27 26.53 ND 26.86 EBUS detected
hsa-miR-138-4395395 20.25 21.76 21.64 22.94 19.64 27.95 26.94 25.35 ND ND EBUS detected
hsa-miR-181c-4373115 29.18 26.87 28.60 28.69 26.79 27.57 29.78 28.40 ND 27.51 EBUS detected
hsa-miR-192-4373108 27.02 25.59 28.02 24.87 23.66 27.50 27.23 25.96 ND 26.11 EBUS detected
hsa-miR-195-4373105 26.77 25.99 26.51 24.20 24.10 23.00 25.26 23.64 ND 24.01 EBUS detected
hsa-miR-296-5p-4373066 24.97 23.88 24.05 26.52 22.94 25.27 28.59 26.54 ND 24.73 EBUS detected
hsa-miR-328-4373049 25.75 24.62 24.79 24.04 25.36 23.87 26.32 24.41 ND 23.00 EBUS detected
hsa-miR-335-4373045 27.39 26.76 27.78 24.53 24.96 25.55 28.35 27.01 ND 27.52 EBUS detected
hsa-miR-361-5p-4373035 27.09 26.28 27.24 26.93 28.57 27.90 29.37 27.79 ND 25.51 EBUS detected
hsa-miR-375-4373027 26.21 23.53 27.27 25.27 19.78 19.91 24.36 23.20 24.61 ND EBUS detected
hsa-miR-454-4395434 25.17 25.28 26.30 24.91 25.21 24.84 26.17 24.63 ND 24.69 EBUS detected
hsa-miR-455-5p-4378098 26.08 25.38 27.27 26.68 26.75 28.09 29.97 29.00 ND 27.64 EBUS detected
hsa-miR-590-5p-4395176 24.45 23.35 25.81 24.48 24.94 27.30 29.88 27.33 ND 27.22 EBUS detected
hsa-miR-10b-4395329 ND ND ND ND ND 28.69 27.21 28.89 22.00 26.13 MED detected
hsa-miR-142-5p-4395359 ND ND ND ND ND 29.14 28.30 26.27 23.27 23.98 MED detected
hsa-miR-142-3p-4373136 ND 28.81 26.31 26.21 25.88 22.56 22.10 20.49 19.66 18.70 MED detected
hsa-miR-143-4395360 ND 29.32 26.00 26.56 27.75 23.71 25.19 24.34 20.24 23.43 MED detected
hsa-miR-214-4395417 ND ND 22.81 24.72 26.89 22.93 24.06 22.24 17.94 22.07 MED detected
hsa-miR-370-4395386 28.87 ND 24.80 27.69 ND 29.18 29.97 28.19 22.16 26.61 MED detected
hsa-miR-451-4373360 ND 27.15 ND ND 27.25 25.90 24.07 23.84 18.64 21.85 MED detected
hsa-miR-518b-4373246 ND ND ND ND ND 15.23 16.05 13.09 ND ND Not detected
hsa-miR-518f-4395499 ND ND ND ND ND 10.97 12.14 8.97 ND ND Not detected
hsa-miR-520a-3p-4373268 ND ND ND ND ND 20.35 19.67 17.91 ND ND Not detected
hsa-miR-548b-3p-4380951 ND ND ND ND ND 20.21 19.56 18.22 ND ND Not detected
hsa-miR-384-4373017 ND ND ND ND ND 23.17 24.42 22.42 24.68 ND Not detected
hsa-miR-520e-4373255 ND ND ND ND ND 22.53 23.31 19.60 ND ND Not detected
hsa-miR-146b-3p-4395472 ND ND ND ND ND 29.66 ND 28.64 ND 26.37 Not detected
hsa-miR-342-5p-4395258 ND ND ND ND ND ND ND ND ND 23.88 Not detected
hsa-miR-486-5p-4378096 ND ND ND ND ND ND ND ND 19.58 26.07 Not detected
hsa-miR-122-4395356 29.70 29.32 29.03 ND 27.66 ND ND ND ND ND Not detected
hsa-miR-625-4395542 29.83 29.05 29.37 29.62 ND ND ND ND ND ND Not detected
hsa-miR-1-4395333 27.65 ND ND ND ND ND ND ND ND ND Not detected
hsa-miR-96-4373372 28.59 26.29 ND 27.11 27.54 ND ND ND ND ND Not detected
hsa-miR-133b-4395358 25.95 ND ND ND ND ND ND ND ND ND Not detected
hsa-miR-147b-4395373 ND 28.23 ND ND ND ND ND ND ND ND Not detected
hsa-miR-182-4395445 28.12 26.89 ND 26.54 27.84 ND ND ND ND ND Not detected
hsa-miR-219-5p-4373080 ND 29.35 ND ND 29.08 ND ND ND ND ND Not detected
hsa-miR-301b-4395503 28.96 27.68 ND 27.49 29.04 ND ND ND ND ND Not detected
hsa-miR-331-5p-4395344 ND 28.36 ND ND ND ND ND ND ND ND Not detected
hsa-miR-409-5p-4395442 ND ND 29.93 ND ND ND ND ND ND ND Not detected
hsa-miR-410-4378093 ND ND 28.54 ND ND ND ND ND ND ND Not detected
hsa-miR-422a-4395408 28.96 29.90 ND 29.07 ND ND ND ND ND ND Not detected
hsa-miR-485-3p-4378095 ND ND 26.24 29.45 ND ND ND ND ND ND Not detected
hsa-miR-487a-4378097 ND ND 29.90 ND ND ND ND ND ND ND Not detected
hsa-miR-487b-4378102 ND ND 28.86 ND ND ND ND ND ND ND Not detected
hsa-miR-493-4395475 ND ND 29.46 ND ND ND ND ND ND ND Not detected
hsa-miR-502-3p-4395194 ND 28.93 ND 29.00 ND ND ND ND ND ND Not detected
hsa-miR-518d-3p-4373248 ND 29.76 ND ND ND ND ND ND ND ND Not detected
hsa-miR-542-3p-4378101 ND 28.95 ND ND ND ND ND ND ND ND Not detected
hsa-miR-579-4395509 ND 28.80 ND 29.06 29.35 ND ND ND ND ND Not detected
hsa-miR-654-5p-4381014 ND ND 29.99 ND ND ND ND ND ND ND Not detected
hsa-miR-655-4381015 ND ND 27.97 ND ND ND ND ND ND ND Not detected
hsa-miR-758-4395180 ND ND 29.65 ND ND ND ND ND ND ND Not detected
hsa-miR-492-4373217 28.08 26.24 ND 28.70 26.18 ND ND ND ND ND Not detected
hsa-miR-129-3p-4373297 ND ND ND 29.23 23.06 ND ND ND ND ND Not detected
hsa-miR-129-5p-4373171 ND ND ND ND 26.35 ND ND ND ND ND Not detected
hsa-miR-190-4373110 ND ND ND 28.44 ND ND ND ND ND ND Not detected
hsa-miR-372-4373029 ND ND ND ND 29.14 ND ND ND ND ND Not detected
hsa-miR-501-3p-4395546 ND ND ND 28.30 ND ND ND ND ND ND Not detected
hsa-miR-508-3p-4373233 ND ND ND ND 29.09 ND ND ND ND ND Not detected
hsa-miR-509-5p-4395346 ND ND ND ND 28.97 ND ND ND ND ND Not detected
hsa-miR-628-5p-4395544 ND ND ND 29.33 ND ND ND ND ND ND Not detected
hsa-miR-629-4395547 ND ND ND 29.79 29.16 ND ND ND ND ND Not detected
hsa-miR-888-4395323 ND ND ND ND 28.05 ND ND ND ND ND Not detected
hsa-miR-891a-4395302 ND ND ND ND 28.04 ND ND ND ND ND Not detected
hsa-miR-211-4373088 ND ND ND 26.37 ND ND ND ND ND ND Not detected
hsa-miR-34c-5p-4373036 26.46 26.36 28.74 28.58 ND 27.08 ND ND ND ND Not detected
hsa-miR-124-4373295 29.28 28.71 29.48 29.45 ND ND ND 29.00 ND ND Not detected
hsa-miR-576-3p-4395462 29.14 27.89 29.75 ND ND ND ND 29.97 ND ND Not detected
hsa-miR-133a-4395357 21.92 29.81 ND ND 28.87 26.01 29.53 28.09 ND 27.00 Not detected
hsa-miR-135a-4373140 26.92 25.71 ND 26.57 25.42 26.84 29.73 29.18 ND ND Not detected
hsa-miR-425-4380926 24.11 23.17 ND 23.53 22.93 24.86 26.23 22.88 ND 23.81 Not detected
hsa-miR-105-4395278 ND ND ND 27.67 ND ND ND 29.56 ND ND Not detected
hsa-miR-139-3p-4395424 ND ND ND ND 25.44 27.19 27.95 ND ND ND Not detected
hsa-miR-184-4373113 ND ND ND 27.13 29.04 27.70 ND ND ND ND Not detected
hsa-miR-187-4373307 ND ND ND ND ND ND ND 23.88 ND ND Not detected
hsa-miR-381-4373020 ND ND ND ND ND ND 26.23 ND ND ND Not detected
hsa-miR-450a-4395414 ND ND ND ND ND ND ND 29.91 ND ND Not detected
hsa-miR-489-4395469 ND ND ND ND 27.95 ND ND 25.99 24.82 ND Not detected
hsa-miR-548b-5p-4395519 ND ND ND ND ND ND ND 29.34 ND ND Not detected
hsa-miR-548c-5p-4395540 ND ND ND ND ND ND ND 29.92 ND ND Not detected
hsa-miR-618-4380996 ND ND ND ND ND ND ND 29.83 ND ND Not detected
hsa-miR-876-5p-4395316 ND ND ND ND ND 27.58 ND ND ND ND Not detected
hsa-miR-885-5p-4395407 ND ND ND ND 28.65 29.64 ND ND ND ND Not detected
hsa-miR-511-4373236 ND ND ND ND ND 29.88 ND ND ND 26.54 Not detected
hsa-miR-520f-4373256 ND ND ND ND ND 21.61 ND ND ND ND Not detected
hsa-miR-125a-3p-4395310 ND 29.24 29.80 29.60 29.19 ND ND ND 24.26 ND Not detected
hsa-miR-134-4373299 ND ND 26.56 29.25 ND ND ND ND 22.57 ND Not detected
hsa-miR-323-3p-4395338 ND ND 28.07 ND ND ND ND ND 24.70 ND Not detected
hsa-miR-449a-4373207 28.91 29.26 ND ND ND ND ND ND 24.80 ND Not detected
hsa-miR-539-4378103 ND ND 27.19 29.97 ND ND ND ND 24.66 ND Not detected
hsa-miR-196b-4395326 ND ND ND 27.35 ND ND ND ND ND 27.69 Not detected
hsa-miR-32-4395220 29.64 29.30 ND ND 29.48 28.86 ND 28.92 ND ND Not detected
hsa-miR-137-4373301 ND 29.02 27.62 ND ND ND ND 29.08 24.73 ND Not detected
hsa-miR-140-3p-4395345 ND 29.12 29.98 ND ND ND ND 29.02 ND 27.73 Not detected
hsa-miR-199a-5p-4373272 ND ND 27.67 ND ND 28.36 ND 27.98 ND 27.61 Not detected
hsa-miR-199b-5p-4373100 ND ND 28.00 ND ND 28.35 ND 28.51 ND 27.80 Not detected
hsa-miR-204-4373094 ND 28.15 ND 24.25 27.55 28.55 ND ND ND 27.31 Not detected
hsa-miR-215-4373084 28.51 27.15 ND 25.14 26.52 ND ND 29.25 ND ND Not detected
hsa-miR-337-5p-4395267 ND ND 29.72 ND ND ND 22.53 ND ND ND Not detected
hsa-miR-362-3p-4395228 ND 28.53 ND ND 29.50 28.96 ND ND ND ND Not detected
hsa-miR-363-4378090 ND 29.91 29.78 27.59 29.25 ND ND 28.95 ND ND Not detected
hsa-miR-379-4373349 ND 29.91 25.84 28.10 28.83 ND ND 29.28 24.79 ND Not detected
hsa-miR-382-4373019 ND 28.63 24.75 29.45 29.03 ND ND 28.87 22.07 ND Not detected
hsa-miR-449b-4381011 28.31 28.29 ND ND ND 29.87 ND 29.82 ND ND Not detected
hsa-miR-483-5p-4395449 ND 29.05 23.98 27.83 27.91 29.94 ND 26.92 24.82 ND Not detected
hsa-miR-494-4395476 ND 29.82 26.87 29.20 ND 29.68 ND 27.96 24.51 ND Not detected
hsa-miR-495-4381078 27.99 ND 25.91 28.21 28.82 ND ND 29.94 ND ND Not detected
hsa-miR-501-5p-4373226 27.23 25.22 ND 25.27 25.54 26.10 ND 25.83 23.91 ND Not detected
hsa-miR-502-5p-4373227 ND 28.19 29.92 28.91 ND 29.64 ND ND ND ND Not detected
hsa-miR-598-4395179 28.20 28.31 ND 26.79 ND 27.64 ND ND ND ND Not detected
hsa-miR-636-4395199 29.61 29.18 ND 29.44 27.98 ND ND 29.89 ND ND Not detected
hsa-miR-33b-4395196 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-127-5p-4395340 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-136-4373173 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-153-4373305 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-154-4373270 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-188-3p-4395217 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-193a-3p-4395361 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-198-4395384 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-202-4395474 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-208b-4395401 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-216a-4395331 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-216b-4395437 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-217-4395448 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-296-3p-4395212 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-299-3p-4373189 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-299-5p-4373188 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-302a-4378070 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-302b-4378071 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-302c-4378072 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-326-4373050 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-329-4373191 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-330-5p-4395341 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-338-3p-4395363 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-367-4373034 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-369-3p-4373032 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-369-5p-4373195 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-371-3p-4395235 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-373-4378073 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-376b-4373196 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-377-4373025 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-380-4373022 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-383-4373018 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-431-4395173 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-433-4373205 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-450b-3p-4395319 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-450b-5p-4395318 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-453-4395429 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-485-5p-4373212 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-486-3p-4395204 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-488-4395468 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-490-3p-4373215 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-491-3p-4395471 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-496-4386771 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-499-3p-4395538 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-499-5p-4381047 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-504-4395195 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-507-4373232 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-508-5p-4395203 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-510-4395352 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-512-3p-4381034 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-512-5p-4373238 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-513-5p-4395201 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-515-3p-4395480 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-515-5p-4373242 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-516a-5p-4395527 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-516b-4395172 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-517a-4395513 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-517c-4373264 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-518a-3p-4395508 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-518a-5p-4395507 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-518c-4395512 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-518d-5p-4395500 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-518e-4395506 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-519a-4395526 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-519d-4395514 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-519e-4395481 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-520a-5p-4378085 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-520d-5p-4395504 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-520g-4373257 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-521-4373259 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-522-4395524 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-523-4395497 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-524-5p-4395174 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-525-3p-4395496 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-525-5p-4378088 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-526b-4395493 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-541-4395312 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-542-5p-4395351 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-544-4395376 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-545-4395378 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-548a-3p-4380948 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-548a-5p-4395523 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-548c-3p-4380993 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-548d-3p-4381008 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-548d-5p-4395348 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-551b-4380945 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-556-3p-4395456 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-556-5p-4395455 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-561-4380938 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-570-4395458 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-576-5p-4395461 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-582-3p-4395510 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-582-5p-4395175 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-589-4395520 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-615-3p-4386777 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-615-5p-4395464 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-616-4395525 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-624-4395541 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-627-4380967 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-651-4381007 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-653-4395403 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-654-3p-4395350 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-672-4395438 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-674-4395193 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-871-4395465 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-872-4395375 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-873-4395467 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-874-4395379 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-875-3p-4395315 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-876-3p-4395336 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-885-3p-4395483 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-887-4395485 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-889-4395313 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-890-4395320 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-891b-4395321 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-892a-4395306 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-147-4373131 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-208-4373091 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-219-1-3p-4395206 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-219-2-3p-4395501 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-220-4373078 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-220b-4395317 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-220c-4395322 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-298-4395301 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-325-4373051 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-346-4373038 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-412-4373199 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-448-4373206 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-506-4373231 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-509-3-5p-4395266 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-517b-4373244 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-519c-3p-4373251 ND ND ND ND ND ND ND ND ND ND Not detected in all
hsa-miR-520b-4373252 ND ND ND ND ND ND ND ND ND ND Not detected in all
Cqn values normalized to RNU6-1 gene are reported. Detected, miRNA detected (Cqn ≤30) in all EBUS or all MED, or in all samples (i.e., “Commonly detected in all”). Not 
detected, miRNA not detected (Cq >30) in EBUS or MED, or in any samples (i.e., “Not detected in all”).EBUS, expression profile of the primary cell lines established from 
EBUS-TBNA specimens; FFPE, formalin-fixed paraffin-embedded; MED, expression profile of lung cancer tissues microdissected from mediastinoscopy FFPE samples;  
ND, not detected.
